Fair Value Distribution — percentile bands
0.0% of simulations place fair value above current price
WHAT IS PRICED IN
Revenue-Based Reverse DCF
16.1%/yr
±4.4% · revenue growth to justify current price
FCF-Based Reverse DCF
9.3%/yr
±2.9% · FCF growth to justify current price
THE GAP
Market pricing margin expansion or capex normalization
Upgrade to premium for full distribution data, sensitivity analysis, and segment breakdowns.
Sign in to unlockColgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally.
No Eagle analysis yet. Request a full review including conviction score, bull/bear cases, and thesis.
No analysis yet
No analysis yet
CL 2025 10-K reveals margin compression (-40 bps to -50 bps non-GAAP) from raw material cost inflation (+420 bps) overwhelming pricing gains and cost savings. Organic growth slowed to +1.4% on volume ...